
Cheap Medicines vs Ethical Medicines: While patients often seek "cheap" or "generic" drugs, doctors typically prescribe "branded" or "ethical" medicines. Generic drugs contain the same Active Pharmaceutical Ingredient (API) and therapeutic effects as branded drugs but are more affordable due to the absence of R&D and patent costs. Ethical medicines are high-priced branded drugs backed by comprehensive clinical data. Despite the price differences, both types must meet strict regulatory standards like GMP and CDSCO approval for safety and efficacy.
The relevance of this topic stems from frequent patient demand for lower-cost medicines, especially in price-sensitive markets. While patients seek affordability, doctors often prescribe branded medicines, which are typically more expensive.
This creates a conflict, often placing pharmacists in a dilemma regarding which medication to dispense when the doctor's prescription differs from the patient's cost preference.
Generic medicines contain the same Active Pharmaceutical Ingredient (API) and offer the same therapeutic effects as branded drugs. They are more affordable because they do not incur costs for R&D or patents. Despite the lower cost, generic medicines must meet strict regulatory standards to ensure safety, efficacy, and quality.
Generic medicines possess the same Active Pharmaceutical Ingredient (API) as their branded counterparts. They are identical in:
API (e.g., Valsartan API for blood pressure medication is the same in both generic and branded).
Strength (e.g., 2mg strength remains consistent).
Dosage Form (e.g., if it's a tablet, both will be tablets).
Route of Administration (e.g., if oral, both will be oral).
Therapeutic Effect: Generics provide the same therapeutic effect as the innovator drug. Their efficacy is never compromised. They are equally effective and have the same onset and duration of action as innovator drugs.
Generic drugs are manufactured after the patent expiry of the original innovator brand. The original patented molecule, protected for approximately 20 years, becomes available for generic production once its patent expires. This allows other manufacturers to produce the same drug, known as a generic product.
Generic medicines are significantly cheaper due to:
No Research and Development (R&D) Costs: The extensive R&D expenses for discovering the original molecule are already borne by the innovator company.
No Patent Cost: Generic manufacturers do not incur costs for patenting the molecule.
Minimal Marketing Expense: Since the drug is already established and known in the market, marketing requirements are significantly reduced.
Reduced Overhead Expenses: The largest cost components (R&D, patent, marketing) are eliminated, leading to a lower final price. Quality is not compromised by the lower price.
There are two main types of generic medicines: Branded Generics and Unbranded/Pure Generics.
| Types of Generic Medicines | ||
|---|---|---|
| Feature | Branded Generics | Unbranded / Pure Generics |
| Manufacturer | Made by established pharmaceutical companies (e.g., Sun Pharma, Mankind) | Often manufactured or promoted by government schemes |
| Branding | Sold under a brand name (e.g., "Dolo" for Paracetamol) | Sold only by their generic salt name (e.g., "Paracetamol Tablet" or "PCM Tablet") |
| Marketing | Marketed by pharma companies; price is lower than innovator but higher than pure generics | Marketed under government schemes; available in government hospitals/outlets |
| Price | Lower than innovator drugs | Lowest price category (very affordable, sometimes βΉ1-2 per tablet) |
| Example | Dolo (for Paracetamol) | Paracetamol (without a brand name) |
Think of "Dolo" as a branded generic because it has a specific brand name attached to it, even though the underlying drug (Paracetamol) is generic. "Paracetamol" sold plainly is an unbranded or pure generic.
All medicines, whether branded, unbranded, ethical, or generic, must adhere to strict regulatory standards in India:
Good Manufacturing Practices (GMP): All drugs must comply with GMP standards under Schedule M of the Drugs and Cosmetics Act.
Central Drugs Standard Control Organization (CDSCO): All medicines must be approved by CDSCO, which is the central drug regulatory body in India.
Pharmacopoeial Standards: Manufacturers must meet the specifications of recognized pharmacopoeias, such as the Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), or United States Pharmacopoeia (USP).
Bioequivalence Studies: For many categories (e.g., injectables), bioequivalence (BE) studies are mandatory for generic drugs. These studies demonstrate that the generic product delivers the same amount of active ingredient to the bloodstream in the same time frame as the innovator drug, ensuring therapeutic equivalence. This is critical for generics as they do not undergo full clinical trials.
Common misconceptions about generic medicines are inaccurate:
Myth 1: Generics are less effective.
Truth: Generics are equally effective as innovator drugs if approved and bioequivalent.
Myth 2: Generics work slower.
Truth: Generics have the same efficacy, therapeutic action, duration of action, and onset of action as branded drugs.
Myth 3: Costly medicines are safer/only expensive ones are safe.
Truth: If properly approved by CDSCO and compliant with pharmacopoeial standards, generics work the same and are just as safe.
The term "cheap medicines" refers to drugs sold at very low prices.
No Scientific Category: "Cheap" is primarily a pricing term and not a scientific classification like "generic" or "branded/ethical."
Quality vs. Price: While "cheap" implies low price, it does not inherently mean poor quality. Generic medicines can also be cheap.
Manufacturers: Often produced by very low-cost brands or local brands that offer heavy discounts. These can include generics, branded generics, or brands with low marketing costs.
While all licensed drugs must meet standards, products marketed purely on "cheapness" can sometimes be associated with:
Unethical Marketing Practices: Aggressive or misleading sales tactics.
Improper Storage Conditions: Compromised drug quality due to poor storage.
Low Retailer Margins/Push Selling: Retailers may have minimal profit margins, leading to "push selling" where distributors or manufacturers pressure them to sell specific low-cost products.
Variability from Small Manufacturers: While valid licenses require adherence to standards, the oversight and quality control among very small manufacturers might be less consistent than larger ones. However, it is crucial that any medicine, even if cheap, must meet all efficacy and regulatory standards if produced under a valid license.
Ethical medicines, also known as branded medicines, are typically prescribed by doctors and promoted through medical representatives (MRs).
Characteristics:
Supported by clinical data and rigorous scientific proof.
Possess a strong brand image and established trust (e.g., Volini).
High-priced due to significant investments in R&D, clinical trials, and extensive marketing.
Manufacturer Goals: Ethical brands aim to maintain brand trust, build strong relationships with doctors, and promote their products based on scientific grounds and proven efficacy. For example, a small Volini tube might cost βΉ120, while a generic pain relief tube could be βΉ20-50, illustrating the significant price difference due to branding and associated costs.
Here is a summary of the key differences:
| Generic vs. Cheap vs. Ethical Medicines | |||
|---|---|---|---|
| Feature | Generic Medicine | Cheap Medicine | Ethical Medicine (Branded) |
| Active Pharmaceutical Ingredient (API) | Same as innovator | Same as innovator (if validly manufactured) | Same as innovator |
| Price | Low | Very low (often with heavy discounts) | High |
| Marketing | Minimal; established product | Discount-driven (e.g., "Buy One Get One") | Strong clinical data, scientific promotion, MRs |
| Bioequivalence Studies | Required for many categories to demonstrate equivalence | Varies, depends on manufacturer and specific product | Strong clinical trial data available |
| Brand Value | Low to Medium | Generally low | High (established trust and image) |
| Patient Perception | Often doubted (though unwarranted) | Often doubted or associated with poor quality | Highly trusted |